(Q31112245)

28 June 2017

title

Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data (English)

1 reference

28 June 2017

1 reference

1 reference

2

Jan Bonhoeffer

1 reference

28 June 2017

Robert P Wise

1

1 reference

28 June 2017

Judy Beeler

3

1 reference

28 June 2017

Hugo Donato

4

1 reference

28 June 2017

Peter Downie

5

1 reference

28 June 2017

Dana Matthews

6

1 reference

28 June 2017

Vitali Pool

7

1 reference

28 June 2017

Marianne Riise-Bergsaker

8

1 reference

28 June 2017

Terhi Tapiainen

9

1 reference

28 June 2017

Frederick Varricchio

10

1 reference

28 June 2017

Brighton Collaboration Thrombocytopenia Working Group

11

1 reference

28 June 2017

language of work or name

English

0 references

publication date

12 March 2007

1 reference

28 June 2017

1 reference

28 June 2017

volume

25

1 reference

28 June 2017

issue

31

1 reference

28 June 2017

page(s)

5717-5724

1 reference

A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenic purpura after recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenia reported in association with hepatitis B and A vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Haematological changes associated with influenza vaccination in people aged over 65: case report and prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenia after immunization of Canadian children, 1992 to 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Pneumococcal-vaccine-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenic purpura after measles vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Vaccination-associated immune thrombocytopenic purpura in five children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Idiopathic thrombocytopenic purpura and MMR vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

The postmarketing safety profile of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Postlicensure safety surveillance for varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Adverse reactions to duck embryo rabies vaccine. Range and incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Antiplatelet antibodies during the course of HIV-preventive vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Safety and Immunogenicity of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Rubella Vaccination and Thrombocytopenia††

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Effect of Live Measles Vaccine on the Platelet Count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

The platelet count and mean platelet volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.067

10.1016/J.VACCINE.2007.02.067

7 January 2021

Identifiers

DOI

1 reference

28 June 2017

1 reference